Hims & Hers Health under investigation by FTC over business practices - report

[Sign on Doorway for the Federal Trade Commission in Washington D.C.]
LD

* The FTC is investigating Hims & Hers Health (NYSE:HIMS [https://seekingalpha.com/symbol/HIMS]) over some of its business practices, including whether the telemedicine company makes it too difficult to cancel subscriptions.
* Shares are down 5% in after-hours trading.
* While the probe itself was disclosed by the company in July 2024, a new report from _Bloomberg_ is the first time details of its have been disclosed.
* The financial news service, citing individuals familiar with the matter, said [https://www.bloomberg.com/news/articles/2025-08-14/ftc-probing-complaints-about-hims-ads-cancellation-practices] that the agency began its investigation following a number of complaints from consumers over Hims & Hers Health's cancellation and advertising policies.

MORE ON HIMS & HERS HEALTH

* Hims & Hers: A High-Risk Bet [https://seekingalpha.com/article/4810285-hims-and-hers-a-high-risk-bet]
* Hims & Hers: From Telehealth To Wellness Hub, The Bright Future [https://seekingalpha.com/article/4809817-hims-hers-stock-bright-future-recent-price-dip-buying-opportunity]
* Hims & Hers: Still Growing After Breakup With Novo Nordisk [https://seekingalpha.com/article/4809604-hims-and-hers-still-growing-after-breakup-with-novo-nordisk]
* Hims & Hers Health CEO discloses sale of over $33M worth of company stock [https://seekingalpha.com/news/4483993-hims-hers-health-stock-down-ceo-insider-sale]
* Hims & Hers projects $2.4B 2025 revenue as it advances global expansion and launches new specialties [https://seekingalpha.com/news/4478050-hims-and-hers-projects-2_4b-2025-revenue-as-it-advances-global-expansion-and-launches-new]